首页> Lancet (London, England)> Considering BCG vaccination to reduce the impact of COVID-19.

Considering BCG vaccination to reduce the impact of COVID-19.

导出 OA

翻译打印收藏纠错

第一作者： Nigel,Curtis

第一单位： Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia; Infectious Diseases Research Group, Murdoch Children's Research Institute, Parkville, VIC, Australia; Infectious Diseases Unit, The Royal Children's Hospital Melbourne, Parkville, VIC 3052, Australia. Electronic address: nigel.curtis@rch.org.au.

作者： Nigel,Curtis ^[1] ; Annie,Sparrow ^[2] ; Tedros A,Ghebreyesus ^[3] ; Mihai G,Netea ^[4]

作者单位： Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia; Infectious Diseases Research Group, Murdoch Children's Research Institute, Parkville, VIC, Australia; Infectious Diseases Unit, The Royal Children's Hospital Melbourne, Parkville, VIC 3052, Australia. Electronic address: nigel.curtis@rch.org.au. ^[1] The Icahn School of Medicine at Mount Sinai, New York, NY, USA. ^[2] WHO, Geneva, Switzerland. ^[3] Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands; Immunology and Metabolism, Life & Medical Sciences Institute, University of Bonn, Bonn, Germany. ^[4]

医学主题词卡介苗(BCG Vaccine);冠状病毒感染(Coronavirus Infections);人类(Humans);疾病大流行(Pandemics);肺炎, 病毒性(Pneumonia, Viral);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1016/S0140-6736(20)31025-4

PMID 32359402

发布时间 2021-01-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交